Obstetrics, gynecology, andrology, sexual and reproductive health

Urogynecology, urinary and fecal incontinence

PubMed Free Full Text

Overactive bladder

Australia

• Australian Journal of General Practice
  • Overactive bladder syndrome: Management and treatment options [2020]

• Better Safer Care
  • Cystoscopy for uncomplicated overactive bladder symptoms

• Medical Services Advisory Committee
  • Transurethral Injection of Botulinum Toxin into the Bladder Wall for Urinary Incontinence due to Neurogenic Detrusor Overactivity [2016]

Australia, New Zealand

• Urological Society of Australia and New Zealand
  • Conjoint Urological Society of Australia and New Zealand (USANZ) and Urogynaecological Society of Australasia (UGSA) Guidelines on the management of adult non-neurogenic overactive bladder [2016]

Austria

• Pharmacoepidemiology and Drug Safety
  • The role of prescription drugs in female overactive bladder syndrome—A population-wide cohort study [2020]

Brazil

• Advances in Therapy
  • Management of Patients with Overactive Bladder in Brazil: A Retrospective Observational Study Using Data From the Brazilian Public Health System [2020]

• Revista da Associação Médica Brasileira
  • Overactive bladder - pharmacological treatment [2019]

Canada

• Canadian Agency for Drugs and Technologies in Health
  • The Use of the Electromotive Drug Administration System in Patients with Overactive Bladder: A Review of the Clinical Effectiveness, Safety, and Cost-Effectiveness [2014]

• Canadian Urological Association
  • CUA guideline on adult overactive bladder [2017]

• Society of Obstetricians and Gynaecologists of Canada
  • Treatments for Overactive Bladder: Focus on Pharmacotherapy [2018]
  • Treatments for Overactive Bladder: Focus on Pharmacotherapy – An Addendum [2017]

China

• International Journal of Molecular Sciences
  • Evaluation and Management of Neurogenic Bladder: What Is New in China? [2015]

Europe

• European Association of Urology
  • Dealing with complex overactive bladder syndrome patient profiles with focus on fesoterodine: in or out of the EAU guidelines? [2017]

France

• Progrès en Urologie
  • Guidelines for practical usage of botulinum toxin type A (BoNTA) for refractory idiopathic overactive bladder management: Translation of French recommendations [2014]

• Toxins
  • Trends in Botulinum Toxin Use among Patients with Multiple Sclerosis: A Population-Based Study [2023]

International

• Drugs & Aging
  • Comparative Safety and Efficacy of Treatments for Overactive Bladder Among Older Adults: A Network Meta-analysis [2020]

• Therapeutic Advances in Urology
  • Update on the management of overactive bladder [2021]

Middle East

• Advances in Therapy
  • The Prevalence of Overactive Bladder Symptoms in Women in Algeria, Egypt, Jordan and Lebanon: A Cross-Sectional Population-Based Survey [2021]

Pakistan

• Pakistan Journal of Medical Sciences
  • Prevalence and associated risk factors among patients with overactive bladder syndrome in Pakistan [2021]

Poland

• Brain Sciences
  • Population-Based Study of Prevalence, Bother and Behavior Related to Treatment for Lower Urinary Tract Symptoms and Overactive Bladder among Polish Neurogenic Patients [2021]

• Ginekologia Polska
  • The Urogynecology Section of the Polish Society of Gynecologists and Obstetricians guidelines on the management of non-neurogenic overactive bladder syndrome in women [2021]

• Scientific Reports
  • Prevalence and bother of lower urinary tract symptoms and overactive bladder in Poland, an Eastern European Study [2020]

Turkey

• Turkish Journal of Urology
  • The attitudes of Urologists and Gynecologists about overactive bladder and treatment of it in Turkey: A questionnaire survey [2017]

United Kingdom

• Journal of Clinical Urology
  • Botulinum toxin-A for the treatment of overactive bladder: UK contributions [2013]

• National Institute for Health and Care Excellence
  • Axonics sacral neuromodulation system for treating refractory overactive bladder [2020]
  • Mirabegron for treating symptoms of overactive bladder [2013]
  • Percutaneous posterior tibial nerve stimulation for overactive bladder syndrome [2010]

• NHS England
  • Sacral Nerve Stimulation for Overactive Bladder [2015]

United States

• American Urogynecologic Society
  • Clinical Consensus Statement: Association of Anticholinergic Medication Use and Cognition in Women With Overactive Bladder [2021]

• American Urological Association
  • Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment 2019 [2019]
  • Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline [2012]

• Journal of Comparative Effectiveness Research
  • Cost-effectiveness of overactive bladder treatments from a US commercial and payer perspective [2023]
  • Healthcare and economic burden of anticholinergic use in adults with overactive bladder: a systematic literature review [2022]

{Related topics}

• Topic
  • Urinary incontinence